128 related articles for article (PubMed ID: 2116784)
21. Fasting specimens not required for routine measurement of plasma apolipoproteins A-I and B.
Hester J; Shephard MD; Walmsley RN; White GH
Ann Clin Biochem; 1989 Jul; 26 ( Pt 4)():374-5. PubMed ID: 2504103
[No Abstract] [Full Text] [Related]
22. Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method.
Sandkamp M; Tambyrajah B; Schriewer H; Assmann G
J Clin Chem Clin Biochem; 1988 Nov; 26(11):685-8. PubMed ID: 3148681
[TBL] [Abstract][Full Text] [Related]
23. [Determination of apolipoproteins AI and B: diagnostic significance and immunochemical methods].
Marcovina S
Ric Clin Lab; 1984; 14 Suppl 2():75-94. PubMed ID: 6442453
[No Abstract] [Full Text] [Related]
24. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
[TBL] [Abstract][Full Text] [Related]
25. Linkage and segregation analyses of apolipoproteins A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: the Bogalusa Heart Study.
Amos CI; Elston RC; Srinivasan SR; Wilson AF; Cresanta JL; Ward LJ; Berenson GS
Genet Epidemiol; 1987; 4(2):115-28. PubMed ID: 3108069
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein profiles in randomly selected smokers and matched controls.
Mölgaard J; Olsson AG
Adv Exp Med Biol; 1990; 273():259-66. PubMed ID: 2126910
[No Abstract] [Full Text] [Related]
27. [Separation of lipoproteins as a function of their apolipoprotein composition. Clinical applications].
Fruchart JC
Ann Biol Clin (Paris); 1986; 44(2):116-21. PubMed ID: 3092704
[No Abstract] [Full Text] [Related]
28. [Changes in AI, B and E apolipoproteins induced by infusion of lipid emulsions in critical patients].
Locati L; Zagara G; Feré A
Minerva Anestesiol; 1989 Dec; 55(12):505-8. PubMed ID: 2517678
[TBL] [Abstract][Full Text] [Related]
29. [Apolipoproteins A and B in cerebrovascular diseases].
Bruck J; Fischer M; Sluga E; Tschabitscher H
Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
[TBL] [Abstract][Full Text] [Related]
30. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
[No Abstract] [Full Text] [Related]
31. [Clinical evaluation of serum apolipoprotein A-I, A-II and B levels in patients with diabetes mellitus].
Ishii S; Sakurabayashi I; Iimura Y; Kawai T
Rinsho Byori; 1987 Mar; 35(3):319-24. PubMed ID: 3112449
[No Abstract] [Full Text] [Related]
32. [Assays of apolipoproteins A and B as atherogenicity factors in aged patients at hospitals].
Hofmann D; Sebbane G; Orellana V; Maury S; Kirkacharian M; Tofis V; Nguyen P
Ann Med Interne (Paris); 1989; 140(1):36-40. PubMed ID: 2660651
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
Haïat R; Bugugnani MJ
Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
[TBL] [Abstract][Full Text] [Related]
34. Factor analysis of plasma lipoprotein components.
Aursnes I; Smith P; Christiansen EN; Berg K
Atherosclerosis; 1988 Feb; 69(2-3):219-24. PubMed ID: 3126750
[TBL] [Abstract][Full Text] [Related]
35. Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B.
Moore RD; Smith CR; Kwiterovich PO; Pearson TA
Am J Med; 1988 May; 84(5):884-90. PubMed ID: 3129938
[TBL] [Abstract][Full Text] [Related]
36. Determination of the respective density distributions of low- and high-density lipoprotein particles in bovine plasma and lymph by immunoassay of apoproteins A-I and B.
Auboiron S; Durand D; Laplaud PM; Levieux D; Bauchart D; Chapman MJ
Reprod Nutr Dev; 1990; Suppl 2():227s. PubMed ID: 2119595
[No Abstract] [Full Text] [Related]
37. Comparable incremental value of standard and nonstandard lipids for coronary heart disease risk assessment in elderly adults: the Three City Study.
Straczek C; Marti-Soler H; Tafflet M; Perier MC; Dupuy AM; Tzourio C; Barberger-Gateau P; Empana JP
J Am Geriatr Soc; 2013 Jul; 61(7):1234-6. PubMed ID: 23855861
[No Abstract] [Full Text] [Related]
38. The relation of apolipoproteins A-I and B in children to myocardial infarction in parents.
van Stiphout WA; Hofman A
N Engl J Med; 1987 Feb; 316(9):548-9. PubMed ID: 3100955
[No Abstract] [Full Text] [Related]
39. Cardiovascular risk--what should be measured?
Frantz ID
Mayo Clin Proc; 1986 May; 61(5):396-8. PubMed ID: 3702499
[No Abstract] [Full Text] [Related]
40. Apoproteins B and A-I and coronary artery disease in humans.
Brunzell JD; Sniderman AD; Albers JJ; Kwiterovich PO
Arteriosclerosis; 1984; 4(2):79-83. PubMed ID: 6422918
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
